nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—ALB—focal segmental glomerulosclerosis	0.944	1	CbGaD
Gatifloxacin—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.0314	CcSEcCtD
Gatifloxacin—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.0291	CcSEcCtD
Gatifloxacin—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.0291	CcSEcCtD
Gatifloxacin—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.0262	CcSEcCtD
Gatifloxacin—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.0253	CcSEcCtD
Gatifloxacin—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.0248	CcSEcCtD
Gatifloxacin—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.0248	CcSEcCtD
Gatifloxacin—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.0218	CcSEcCtD
Gatifloxacin—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.0217	CcSEcCtD
Gatifloxacin—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.021	CcSEcCtD
Gatifloxacin—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.0199	CcSEcCtD
Gatifloxacin—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.0198	CcSEcCtD
Gatifloxacin—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.0194	CcSEcCtD
Gatifloxacin—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.019	CcSEcCtD
Gatifloxacin—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.0183	CcSEcCtD
Gatifloxacin—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000974	0.0174	CcSEcCtD
Gatifloxacin—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00097	0.0173	CcSEcCtD
Gatifloxacin—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000954	0.017	CcSEcCtD
Gatifloxacin—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00095	0.017	CcSEcCtD
Gatifloxacin—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.000913	0.0163	CcSEcCtD
Gatifloxacin—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00085	0.0152	CcSEcCtD
Gatifloxacin—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.000821	0.0147	CcSEcCtD
Gatifloxacin—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.000818	0.0146	CcSEcCtD
Gatifloxacin—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.000801	0.0143	CcSEcCtD
Gatifloxacin—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.000788	0.0141	CcSEcCtD
Gatifloxacin—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000786	0.014	CcSEcCtD
Gatifloxacin—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.000749	0.0134	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000723	0.0129	CcSEcCtD
Gatifloxacin—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000697	0.0124	CcSEcCtD
Gatifloxacin—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000695	0.0124	CcSEcCtD
Gatifloxacin—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.000681	0.0122	CcSEcCtD
Gatifloxacin—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000674	0.012	CcSEcCtD
Gatifloxacin—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000642	0.0115	CcSEcCtD
Gatifloxacin—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000637	0.0114	CcSEcCtD
Gatifloxacin—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000618	0.011	CcSEcCtD
Gatifloxacin—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000598	0.0107	CcSEcCtD
Gatifloxacin—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000576	0.0103	CcSEcCtD
Gatifloxacin—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00055	0.00983	CcSEcCtD
Gatifloxacin—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000548	0.00979	CcSEcCtD
Gatifloxacin—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000547	0.00977	CcSEcCtD
Gatifloxacin—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000542	0.00969	CcSEcCtD
Gatifloxacin—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000537	0.00959	CcSEcCtD
Gatifloxacin—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000526	0.0094	CcSEcCtD
Gatifloxacin—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000523	0.00935	CcSEcCtD
Gatifloxacin—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.000513	0.00917	CcSEcCtD
Gatifloxacin—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00051	0.00911	CcSEcCtD
Gatifloxacin—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000502	0.00896	CcSEcCtD
Gatifloxacin—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000484	0.00864	CcSEcCtD
Gatifloxacin—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000482	0.00861	CcSEcCtD
Gatifloxacin—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000475	0.00849	CcSEcCtD
Gatifloxacin—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000475	0.00849	CcSEcCtD
Gatifloxacin—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000475	0.00849	CcSEcCtD
Gatifloxacin—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000474	0.00846	CcSEcCtD
Gatifloxacin—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00046	0.00821	CcSEcCtD
Gatifloxacin—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000456	0.00814	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000456	0.00814	CcSEcCtD
Gatifloxacin—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000453	0.00809	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000446	0.00797	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000441	0.00787	CcSEcCtD
Gatifloxacin—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000434	0.00776	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000415	0.00742	CcSEcCtD
Gatifloxacin—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000412	0.00736	CcSEcCtD
Gatifloxacin—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000409	0.00731	CcSEcCtD
Gatifloxacin—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000406	0.00726	CcSEcCtD
Gatifloxacin—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000405	0.00724	CcSEcCtD
Gatifloxacin—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000401	0.00717	CcSEcCtD
Gatifloxacin—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000396	0.00708	CcSEcCtD
Gatifloxacin—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00039	0.00696	CcSEcCtD
Gatifloxacin—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000376	0.00671	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000373	0.00666	CcSEcCtD
Gatifloxacin—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000362	0.00647	CcSEcCtD
Gatifloxacin—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00036	0.00644	CcSEcCtD
Gatifloxacin—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00036	0.00644	CcSEcCtD
Gatifloxacin—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000336	0.006	CcSEcCtD
Gatifloxacin—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000327	0.00584	CcSEcCtD
Gatifloxacin—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000322	0.00576	CcSEcCtD
Gatifloxacin—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000312	0.00557	CcSEcCtD
Gatifloxacin—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000301	0.00538	CcSEcCtD
Gatifloxacin—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00029	0.00518	CcSEcCtD
Gatifloxacin—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000287	0.00513	CcSEcCtD
Gatifloxacin—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000287	0.00513	CcSEcCtD
Gatifloxacin—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000286	0.0051	CcSEcCtD
Gatifloxacin—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000271	0.00484	CcSEcCtD
